KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Supernus Pharmaceuticals (SUPN) Cost of Revenue (2016 - 2025)

Supernus Pharmaceuticals has reported Cost of Revenue over the past 13 years, most recently at $23.0 million for Q4 2025.

  • Quarterly Cost of Revenue fell 11.84% to $23.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $74.6 million through Dec 2025, down 4.29% year-over-year, with the annual reading at $74.6 million for FY2025, 4.29% down from the prior year.
  • Cost of Revenue was $23.0 million for Q4 2025 at Supernus Pharmaceuticals, up from $19.0 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $26.1 million in Q4 2024 and troughed at $15.0 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $19.3 million (2023), against an average of $19.9 million.
  • Year-over-year, Cost of Revenue surged 260.16% in 2021 and then crashed 30.48% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $17.0 million in 2021, then skyrocketed by 35.07% to $23.0 million in 2022, then dropped by 14.49% to $19.6 million in 2023, then skyrocketed by 32.97% to $26.1 million in 2024, then fell by 11.84% to $23.0 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Cost of Revenue are $23.0 million (Q4 2025), $19.0 million (Q3 2025), and $16.8 million (Q2 2025).